Published in Hypertension on April 01, 2001
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest (2009) 4.12
Possible mechanical roles of glycosaminoglycans in thoracic aortic dissection and associations with dysregulated transforming growth factor-β. J Vasc Res (2012) 2.16
Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ Res (2003) 2.13
Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension. Hypertension (2008) 2.09
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest (2005) 1.89
Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag (2007) 1.88
Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction. Hypertension (2008) 1.76
Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension (2009) 1.38
New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides (2011) 1.32
Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J (2008) 1.22
Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler Thromb Vasc Biol (2008) 1.21
Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging. Am J Physiol Heart Circ Physiol (2009) 1.21
Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev (2002) 1.16
The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflam (2014) 1.13
Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem (2014) 1.11
Adventures in vascular biology: a tale of two mediators. Philos Trans R Soc Lond B Biol Sci (2006) 1.10
Selective knockdown of AT1 receptors by RNA interference inhibits Val5-ANG II endocytosis and NHE-3 expression in immortalized rabbit proximal tubule cells. Am J Physiol Cell Physiol (2007) 1.10
Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells. J Renin Angiotensin Aldosterone Syst (2007) 1.04
ACE2 activation promotes antithrombotic activity. Mol Med (2010) 1.04
Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic aorta. Circulation (2009) 1.03
Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species. Atherosclerosis (2007) 0.99
Angiotensin II and nitric oxide interaction. Heart Fail Rev (2002) 0.98
Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney. Am J Physiol Regul Integr Comp Physiol (2011) 0.97
New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms. Front Endocrinol (Lausanne) (2013) 0.95
Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model. Exp Diabetes Res (2011) 0.94
Nigella sativa and Its Protective Role in Oxidative Stress and Hypertension. Evid Based Complement Alternat Med (2013) 0.94
Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo. Atherosclerosis (2008) 0.93
In vivo assessment of blood flow patterns in abdominal aorta of mice with MRI: implications for AAA localization. Am J Physiol Heart Circ Physiol (2009) 0.93
Use of Angiotensin receptor blockers in cardiovascular protection: current evidence and future directions. P T (2011) 0.92
The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. Vasc Health Risk Manag (2007) 0.91
Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system. J Cell Physiol (2011) 0.91
Clinical relevance of local Renin Angiotensin systems. Front Endocrinol (Lausanne) (2014) 0.89
The counter-regulatory effects of ESE-1 during angiotensin II-mediated vascular inflammation and remodeling. Am J Hypertens (2010) 0.89
Angiotensinergic stimulation of vascular endothelium in mice causes hypotension, bradycardia, and attenuated angiotensin response. Proc Natl Acad Sci U S A (2006) 0.89
ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression. Am J Physiol Heart Circ Physiol (2005) 0.88
Effects of smoking cessation on central blood pressure and arterial stiffness. Vasc Health Risk Manag (2011) 0.88
Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species. Cardiovasc Res (2011) 0.87
Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme. Vasc Health Risk Manag (2007) 0.87
Increased migration of monocytes in essential hypertension is associated with increased transient receptor potential channel canonical type 3 channels. PLoS One (2012) 0.87
Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders. Pharmacol Rev (2016) 0.87
Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes. J Hypertens (2009) 0.85
Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects. Br J Clin Pharmacol (2004) 0.85
The angiotensin II receptor type 2 agonist CGP 42112A stimulates NO production in the porcine jejunal mucosa. BMC Pharmacol (2003) 0.85
Morphine induces albuminuria by compromising podocyte integrity. PLoS One (2013) 0.84
The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failure. J Cell Mol Med (2008) 0.83
Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury. Clin Exp Nephrol (2011) 0.83
Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization. Am J Physiol Heart Circ Physiol (2011) 0.83
Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease. Arthritis Res Ther (2010) 0.83
Vascular wall ACE is not required for atherogenesis in ApoE(-/-) mice. Atherosclerosis (2009) 0.82
A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells. Biochem Biophys Res Commun (2012) 0.82
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy. Vasc Health Risk Manag (2008) 0.82
The vascular renin-angiotensin system contributes to blunted vasodilation induced by transient high pressure in human adipose microvessels. Am J Physiol Heart Circ Physiol (2014) 0.81
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors. Vasc Health Risk Manag (2009) 0.81
Neurohormonal intervention to reduce sudden cardiac death in heart failure: what is the optimal pharmacologic strategy? Heart Fail Rev (2004) 0.81
Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants. Br J Clin Pharmacol (2012) 0.80
Valsartan in the treatment of heart attack survivors. Vasc Health Risk Manag (2006) 0.80
ACE as a mechanosensor to shear stress influences the control of its own regulation via phosphorylation of cytoplasmic Ser(1270). PLoS One (2011) 0.80
Renin-sensitive microRNAs correlate with atherosclerosis plaque progression. J Hum Hypertens (2013) 0.79
Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction. Biomaterials (2013) 0.79
Aliskiren effect on plaque progression in established atherosclerosis using high resolution 3D MRI (ALPINE): a double-blind placebo-controlled trial. J Am Heart Assoc (2013) 0.79
Sodium ferulate inhibits neointimal hyperplasia in rat balloon injury model. PLoS One (2014) 0.79
Intracrine renin and angiotensin II: a novel role in cardiovascular and renal cellular regulation. J Hypertens (2006) 0.79
Comparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type 2 diabetic patients. J Diabetes Investig (2011) 0.79
Angiotensin-converting enzyme gene and retinal arteriolar narrowing: the Funagata Study. J Hum Hypertens (2009) 0.79
Endothelial cell markers in patients with pseudoexfoliation syndrome. ScientificWorldJournal (2012) 0.79
Effects of allisartan, a new AT(1) receptor blocker, on blood pressure and end-organ damage in hypertensive animals. Acta Pharmacol Sin (2009) 0.78
Effects of hydrogen-rich water on abnormalities in a SHR.Cg-Leprcp/NDmcr rat - a metabolic syndrome rat model. Med Gas Res (2011) 0.78
Effect of repeatedly heated palm olein on blood pressure-regulating enzymes activity and lipid peroxidation in rats. Malays J Med Sci (2012) 0.78
Managing CKD: key therapeutic issues introduction. Clin J Am Soc Nephrol (2008) 0.78
Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition. Clinics (Sao Paulo) (2012) 0.78
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors. Ther Clin Risk Manag (2009) 0.78
Handle Region Peptide Ameliorating Insulin Resistance but Not β Cell Functions in Male Rats Neonatally Treated with Sodium L-Glutamate. Int J Endocrinol (2013) 0.78
Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC). J Biol Chem (2013) 0.78
Local bone marrow Renin-Angiotensin system and atherosclerosis. Cardiol Res Pract (2010) 0.77
Nitric oxide and cardiovascular protection. Heart Fail Rev (2003) 0.77
Effects of valsartan on inflammatory and oxidative stress markers in hypertensive, hyperglycemic patients: an open-label, prospective study. Curr Ther Res Clin Exp (2007) 0.77
Endothelial Dysfunction in Type 2 Diabetes Mellitus. Indian J Clin Biochem (2015) 0.76
Newer approaches to genetic modeling in mice: tissue-specific protein expression as studied using angiotensin-converting enzyme (ACE). Am J Pathol (2003) 0.76
Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions. Antioxid Redox Signal (2015) 0.75
Effects of taxifolin on the activity of angiotensin-converting enzyme and reactive oxygen and nitrogen species in the aorta of aging rats and rats treated with the nitric oxide synthase inhibitor and dexamethasone. Age (Dordr) (2012) 0.75
Hyponatremia and increased risk of dementia: A population-based retrospective cohort study. PLoS One (2017) 0.75
Clinical trial update: focus on the ONTARGET study. Vasc Health Risk Manag (2007) 0.75
Aliskiren and valsartan combination therapy for the management of hypertension. Vasc Health Risk Manag (2010) 0.75
Relationship between the receptor occupancy profile and pleiotropic effects of angiotensin II receptor blockers. Br J Clin Pharmacol (2013) 0.75
Hyperhomocysteinemia accelerates collagen accumulation in the adventitia of balloon-injured rat carotid arteries via angiotensin II type 1 receptor. Int J Mol Sci (2014) 0.75
Endothelial Nitric Oxide Synthase and Angiotensin Converting Enzyme Gene Polymorphisms in Migraine Patients. Noro Psikiyatr Ars (2013) 0.75
Exercise Training Attenuates Upregulation of p47(phox) and p67(phox) in Hearts of Diabetic Rats. Oxid Med Cell Longev (2016) 0.75
Relationship between angiotensin I-converting enzyme insertion/deletion gene polymorphism and retinal vein occlusion. Thromb J (2014) 0.75
Association of genome variations in the renin-angiotensin system with physical performance. Hum Genomics (2012) 0.75
Aliskiren: An orally active renin inhibitor. J Pharm Bioallied Sci (2011) 0.75
Angiotensin-converting enzyme insertion/deletion polymorphism is not associated with vasoocclusive complications of sickle cell anemia. Int J Appl Basic Med Res (2016) 0.75
Association of serum sodium concentration with coronary atherosclerosis in China: follow-up study. Acta Pharmacol Sin (2009) 0.75
Angiotensinase C mRNA and Protein Downregulations Are Involved in Ethanol-Deteriorated Left Ventricular Systolic Dysfunction in Spontaneously Hypertensive Rats. Biomed Res Int (2015) 0.75
Associations between elevated resting heart rate and subclinical atherosclerosis in asymptomatic Korean adults undergoing coronary artery calcium scoring. Int J Cardiovasc Imaging (2016) 0.75
The Presence of Anti-Angiotensin II Type-1 Receptor Antibodies Adversely Affect Kidney Graft Outcomes. Int J Environ Res Public Health (2017) 0.75